BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37394259)

  • 1. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
    Thomas EG; Thomas DJ
    Immunol Allergy Clin North Am; 2023 Aug; 43(3):553-568. PubMed ID: 37394259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
    Thomas EG; Thomas DJ
    Emerg Med Clin North Am; 2022 Feb; 40(1):119-133. PubMed ID: 34782083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
    Lyons JJ; Greiner G; Hoermann G; Metcalfe DD
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary alpha-tryptasemia.
    Bonadonna P; Nalin F; Olivieri F
    Curr Opin Allergy Clin Immunol; 2022 Oct; 22(5):277-282. PubMed ID: 35942852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
    Shin H; Lyons JJ
    Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
    Sordi B; Vanderwert F; Crupi F; Gesullo F; Zanotti R; Bonadonna P; Crosera L; Elena C; Fiorelli N; Ferrari J; Grifoni F; Sciumè M; Parente R; Triggiani M; Palterer B; Mecheri V; Almerigogna F; Santi R; Di Medio L; Brandi ML; Iorno ML; Ciardetti I; Bencini S; Annunziato F; Mannarelli C; Pieri L; Guglielmelli P; Mannelli F; Vannucchi AM
    J Allergy Clin Immunol; 2023 Feb; 151(2):485-493.e11. PubMed ID: 36309122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia.
    Giannetti MP; Godwin G; Weller E; Butterfield JH; Castells M
    J Allergy Clin Immunol; 2022 Nov; 150(5):1225-1227. PubMed ID: 35550148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
    Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis and related entities: a practical roadmap.
    Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
    Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia.
    Luskin KT; White AA; Lyons JJ
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
    Kačar M; Rijavec M; Šelb J; Korošec P
    Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with elevated basal tryptase serum levels should be tested for hereditary alpha-tryptasemia.
    Spoerl D; Docquier M; Coattrenec Y; Seebach JD
    Eur Ann Allergy Clin Immunol; 2022 Sep; 54(5):242-244. PubMed ID: 34124865
    [No Abstract]   [Full Text] [Related]  

  • 13. Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.
    Wu R; Lyons JJ
    Curr Allergy Asthma Rep; 2021 May; 21(5):33. PubMed ID: 33970354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.
    Gulen T
    Immunol Allergy Clin North Am; 2023 Nov; 43(4):681-698. PubMed ID: 37758406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylaxis and Mast Cell Disorders.
    Gülen T; Akin C
    Immunol Allergy Clin North Am; 2022 Feb; 42(1):45-63. PubMed ID: 34823750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
    Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
    González-de-Olano D; Navarro-Navarro P; Muñoz-González JI; Sánchez-Muñoz L; Henriques A; de-Andrés-Martín A; Peralta-Arjonilla D; Mayado A; Jara-Acevedo M; García-Montero AC; Orfao A; Álvarez-Twose I
    Allergy; 2024 Mar; 79(3):711-723. PubMed ID: 37818990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
    Polivka L; Madrange M; Bulai-Livideanu C; Barete S; Ballul T; Neuraz A; Greco C; Agopian J; Brenet F; Dubreuil P; Burdet C; Lemal R; Tournilhac O; Terriou L; Launay D; Bouillet L; Gourguechon C; Damaj G; Frenzel L; Meni C; Bouktit H; Collange AF; Gaudy-Marqueste C; Gousseff M; Le Mouel E; Hamidou M; Neel A; Ranta D; Jaussaud R; Guilpain P; Canioni D; Molina TJ; Bruneau J; Lhermitte L; Garcelon N; Javier RM; Pelletier F; Castelain F; Retornaz F; Cabrera Q; Zunic P; Gourin MP; Wierzbicka-Hainaut E; Viallard JF; Lavigne C; Hoarau C; Durieu I; Heiblig M; Dimicoli-Salazar S; Torregrosa-Diaz JM; Soria A; Arock M; Lortholary O; Bodemer C; Hermine O; Rossignol J;
    J Allergy Clin Immunol; 2024 Jan; 153(1):349-353.e4. PubMed ID: 37633651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: are we there yet?
    Couto ML; Silva M; Barbosa MJ; Ferreira F; Fragoso AS; Azenha Rama T
    Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):152-160. PubMed ID: 36927821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
    Zaghmout T; Maclachlan L; Bedi N; Gülen T
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.